Vertigo is a medical condition where a person feels as if they or the objects around them are moving when they are not. Often it feels like a spinning or swaying movement.
- Agency -.
This may be associated with nausea, vomiting, sweating, or difficulties walking. It is typically worsened when the head is moved.
- Agency -.
Complete report on Global Vertigo Market spread across 61 pages with providing 4 company profiles, 10 tables and 28 charts is now available at www.marketreportsonline.com/701208.html.
Vertigo is the most common type of dizziness. The causes for vertigo can be divided into two categories: Peripheral and Central.
Peripheral is linked to the inner ear whereas central is linked to problems in Central Nervous System.
Peripheral vertigo can be further segmented into five major categories: Benign paroxysmal positional vertigo (BPPV), Acute Unilateral Vestibulopathy, Meniere’s disease and Vestibular Schwannoma. Amongst all the stated indication, Meniere’s disease represents the largest growth opportunity for the market players with its continuously rising incidence.
Growth of global vertigo market is expected to be driven by factors such as rising incidence and prevalence of peripheral etiologies of vertigo, increasing geriatric population, growing healthcare expenditure and improving disposable income. Further, the market growth could be hindered by side effects of currently prescribed medication, the high cost of treatment and tedious drug approval process.
The key trends for the market include extensive research & development and different approaches being adopted by drug manufacturers in order to target vertigo.
Access a copy of this “Global Vertigo Market” research report at www.marketreportsonline.com/contac…e.php?name=701208.
A key drug Otividex, which is currently in third phase of clinical trials and is being developed by Otonomy Inc., is discussed in the report. The drug is easier to use and provides a higher and sustained concentration of dexamethasone relative to existing injections.
Further, it is anticipated to provide a well-accepted treatment option for Meniere’s Disease, if successfully developed.
The report “Global Vertigo Market: Industry Analysis & Outlook (2017-2021)” analyzes the development of this market, with focus on Europe and US regions. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report.
The four major players involved in the development of breakthrough drug therapy for vertigo: Auris Medical Holding AG., Sensorion SA, Otonomy, Inc. and Sound Pharmaceuticals, Inc.
are being profiled along with their key financials and strategies for growth.
Few Points from List of Tables Provided in Global Vertigo Market:
Common Causes of Peripheral and Central Vestibular Disorders
Incidence and Prevalence of Peripheral Etiologies of Vertigo per 100,000 (2016)
Vertigo Drugs in Development (2016)
Current Treatments Therapies for Vertigo & Side Effects
Market Cap. Comparison by Companies (2016)
Product Comparison by Companies (2016)
Auris’s Key Drugs Under Pipeline (2017)
Sensorion’s Key Drug Pipeline (2017)
Otonomy’s Key Drugs Under Pipeline (2017)
Sound’s Key Drug Pipeline (2017)
Category: Market Research Publishers and RetailersCompany profile: MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
For more information: